trial
as of 2026-07-01Oxytocin-Augmented Group Psychotherapy for Patients With Schizophrenia - an Oxytocin-dose Comparison
NCTId NCT07265180
at a glance
— · Recruiting
Enrollment 120 (estimated)
Sponsored by Charite University, Berlin, Germany
Primary completion 2026-11-30
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Recruiting
Enrollment
120 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2025-09-08
Primary completion
2026-11-30
Eligibility
ALL · 18 Years · 75 Years
Interventions & indications
Drugs
Indications
Sponsors
Charite University, Berlin, GermanyLead Sponsor
Investigators
3
Marco Zierhut, Dr.Principal Investigator
Kerem Böge, Prof.Principal Investigator
Eric Hahn, PDPrincipal Investigator
Sites
1 total
Berlin, Germany
Facts & assertions
4 sourced
Enrollment
120
Phase
NA
Primary Completion Date
2026-11-30
Status
RECRUITING
relationships
The graph out of here
drug
drug
lead_sponsor
indication
indication
investigator